Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease

酒精

基本信息

  • 批准号:
    8278027
  • 负责人:
  • 金额:
    $ 44.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-30 至 2014-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chronic alcohol consumption is associated with increased hepatic oxidative stress and reduced antioxidant defense resulting in alcohol-induced liver injury. Nucleoside reverse transcriptase inhibitors (NRTI) in combination with non-NRTIs and protease inhibitors have demonstrated their effectiveness as antiretroviral drugs against HIV-1 despite their well-described side-effects, including liver toxicity. While these side-effects are multi-factorial, oxidative stress and mitochondrial DNA damage has been suggested to play a key role. Mitochondrial DNA damage and increased oxidative stress produced by antiretroviral treatment (ART) may be aggravated by alcoholism, as chronic alcohol consumption is associated with increased hepatic oxidative stress and reduced antioxidant defense resulting in alcohol-induced liver injury. We propose to follow a cohort of 260 HIV infected ART naive participants, 65 patients who are being initiated on ART and are heavy alcohol users (Group 1), 65 patients who are being initiated on ART and do not drink alcohol or are moderate alcohol drinkers (Group 2), 65 patients who are early in HIV disease and are not being initiated on ART and are heavy alcohol users (Group 3), 65 patients who are early in HIV disease and are not being initiated on ART and do not drink alcohol or are moderate alcohol drinkers (Group 4), for 2 years. HIV staging (CD4 and viral load) co- morbidities, ART and other treatments will be documented. Questionnaires on demographics, BMI, food intake, and use of micronutrient supplements will be obtained and treated as covariates. ART will be restricted, and co-morbid conditions which are associated with oxidative stress, will be excluded before the baseline visit. Blood will be drawn for oxidative stress (malondialdehyde to indicate lipid peroxidation, protein carbonyls for protein oxidation, 8-hydroxyguanosine for DNA oxidation). Mitochondrial damage will be assessed with quantitative and qualitative changes in mitochondrial DNA content and with plasma lactate. Hepatocellular injury and function will be determined with plasma levels of ALT, AST, platelets, albumin, hyaluronic acid and total and conjugated bilirubin. Plasma antioxidants (glutathione, vitamins A and E, 1 and 2-carotenes, zinc and selenium) will also be determined. This proposal will determine the combined effects of chronic alcohol consumption and antiretroviral therapy on oxidative stress, antioxidant status, mitochondrial toxicity and liver dysfunction to provide the basis for potential preventive therapeutic approaches to protect the liver from alcohol and antiretroviral drug induced injury. PUBLIC HEALTH RELEVANCE: The objective of this proposal is to determine the combined effects of chronic alcohol consumption and antiretroviral therapy on oxidative stress, antioxidant status, mitochondrial toxicity and liver dysfunction, and to determine the effect of increased oxidative stress and nutritional deficiencies that might occur with chronic alcoholism on HIV-associated mitochondrial DNA damage. A better appreciation for alcohol's effects on HIV and liver disease may increase utilization of alcohol cessation interventions, thus improving treatment outcomes and providing the basis for potential preventive therapeutic approaches to protect liver from alcohol and antiretroviral drug-induced liver injury.
描述(由申请人提供):长期饮酒与肝脏氧化应激增加和抗氧化防御能力降低有关,导致酒精性肝损伤。核苷逆转录酶抑制剂 (NRTI) 与非 NRTI 和蛋白酶抑制剂联合使用,已证明其作为抗逆转录病毒药物对抗 HIV-1 的有效性,尽管其副作用已广为人知,包括肝毒性。虽然这些副作用是多因素造成的,但氧化应激和线粒体 DNA 损伤被认为起着关键作用。酗酒可能会加剧抗逆转录病毒治疗 (ART) 产生的线粒体 DNA 损伤和氧化应激增加,因为长期饮酒与肝脏氧化应激增加和抗氧化防御能力降低有关,从而导致酒精性肝损伤。我们建议对 260 名感染 HIV 的未接受 ART 的参与者、65 名正在接受 ART 且酗酒的患者(第 1 组)、65 名正在接受 ART 且不饮酒或适度饮酒的患者进行跟踪(第 2 组),65 名处于 HIV 疾病早期且未开始接受 ART 且酗酒的患者(第 3 组),65 名处于 HIV 疾病早期且未开始接受 ART 治疗的患者,以及两年内不饮酒或适度饮酒(第 4 组)。 HIV 分期(CD4 和病毒载量)合并症、ART 和其他治疗将被记录。将获得有关人口统计、体重指数、食物摄入量和微量营养素补充剂使用的调查问卷,并将其视为协变量。 ART 将受到限制,并且在基线访视之前将排除与氧化应激相关的共病。抽取血液用于氧化应激(丙二醛用于指示脂质过氧化,蛋白质羰基用于蛋白质氧化,8-羟基鸟苷用于DNA氧化)。线粒体损伤将通过线粒体 DNA 含量和血浆乳酸的定量和定性变化来评估。肝细胞损伤和功能将通过血浆 ALT、AST、血小板、白蛋白、透明质酸以及总胆红素和结合胆红素的水平来确定。血浆抗氧化剂(谷胱甘肽、维生素 A 和 E、1 和 2-胡萝卜素、锌和硒)也将被测定。该提案将确定长期饮酒和抗逆转录病毒治疗对氧化应激、抗氧化状态、线粒体毒性和肝功能障碍的综合影响,为保护肝脏免受酒精和抗逆转录病毒药物引起的损伤的潜在预防性治疗方法提供基础。 公共健康相关性:本提案的目的是确定长期饮酒和抗逆转录病毒治疗对氧化应激、抗氧化状态、线粒体毒性和肝功能障碍的综合影响,并确定氧化应激增加和可能发生的营养缺乏的影响慢性酒精中毒对 HIV 相关线粒体 DNA 的损伤。更好地认识酒精对艾滋病毒和肝病的影响可能会增加戒酒干预措施的使用,从而改善治疗结果,并为保护肝脏免受酒精和抗逆转录病毒药物引起的肝损伤的潜在预防性治疗方法提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marianna K Baum其他文献

Drug use and COVID-19 testing, vaccination, and infection among underserved, minority communities in Miami, Florida.
佛罗里达州迈阿密服务欠缺的少数族裔社区的药物使用和 COVID-19 检测、疫苗接种和感染。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Javier A. Tamargo;H. Martin;Janet Diaz;I. Delgado;Angelique Johnson;Jose A Bastida Rodriguez;M. Trepka;David R Brown;Nana A Garba;Eneida O Roldan;Yolangel Hernandez Suarez;Aileen M Marty;Zoran Bursac;A. Campa;Marianna K Baum
  • 通讯作者:
    Marianna K Baum
Detection of SARS-CoV-2 in high-efficiency particulate air (HEPA) filters of low-cost air purifiers in community-based organizations
在社区组织的低成本空气净化器的高​​效颗粒空气 (HEPA) 过滤器中检测 SARS-CoV-2
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Rachel D. Clarke;N. A. Garba;Manuele Barbieri;Leonardo Acuna;Marianna K Baum;Maribel Saad Rodriguez;Hansel Frias;Paulina Saldarriaga;Troy Stefano;K. Mathee;G. Narasimhan;David R. Brown
  • 通讯作者:
    David R. Brown
Community-Engaged Research: COVID-19 Testing, Infection, and Vaccination among Underserved Minority Communities in Miami, Florida
社区参与研究:佛罗里达州迈阿密服务不足的少数族裔社区的 COVID-19 检测、感染和疫苗接种
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    H. Martin;David R Brown;Eileen Fluney;M. Trepka;Aileen M Marty;Eneida O Roldan;Qingyun Liu;Manuel A. Barbieri;Marianna K Baum
  • 通讯作者:
    Marianna K Baum

Marianna K Baum的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marianna K Baum', 18)}}的其他基金

Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
  • 批准号:
    10447463
  • 财政年份:
    2022
  • 资助金额:
    $ 44.49万
  • 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations Phase II
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究第二阶段
  • 批准号:
    10544758
  • 财政年份:
    2022
  • 资助金额:
    $ 44.49万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9494556
  • 财政年份:
    2015
  • 资助金额:
    $ 44.49万
  • 项目类别:
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable Populations
社区参与的针对服务不足和/或弱势群体的 COVID-19 检测研究
  • 批准号:
    10662839
  • 财政年份:
    2015
  • 资助金额:
    $ 44.49万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9927614
  • 财政年份:
    2015
  • 资助金额:
    $ 44.49万
  • 项目类别:
Cohort Studies on HIV/AIDS and Substance Abuse in Miami
迈阿密艾滋病毒/艾滋病和药物滥用队列研究
  • 批准号:
    9144756
  • 财政年份:
    2015
  • 资助金额:
    $ 44.49万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7590839
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7691806
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    8080463
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7857921
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:

相似国自然基金

基于核酸适配体-纳米胶束的荧光多标记生物传感器检测8-羟基-2'-脱氧鸟苷
  • 批准号:
    21507020
  • 批准年份:
    2015
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
乙型肝炎病毒X蛋白促进8-OHdG介导的致肝细胞DNA突变作用及机制
  • 批准号:
    81572007
  • 批准年份:
    2015
  • 资助金额:
    75.0 万元
  • 项目类别:
    面上项目
孕妇对环境内分泌干扰物的暴露、来源解析及健康风险评价
  • 批准号:
    21577050
  • 批准年份:
    2015
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目
电喷雾解吸/萃取电离质谱快速检测尿中羟基多环芳烃研究
  • 批准号:
    21107066
  • 批准年份:
    2011
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
DNA氧化损伤标志物8-羟基脱氧鸟苷的高灵敏、高选择性电化学检测及其应用研究
  • 批准号:
    21075059
  • 批准年份:
    2010
  • 资助金额:
    38.0 万元
  • 项目类别:
    面上项目

相似海外基金

Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
  • 批准号:
    8601204
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
  • 批准号:
    8788960
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
  • 批准号:
    8297360
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
Microdialysis Studies of Seizure-Induced Oxidative Stress
癫痫发作引起的氧化应激的微透析研究
  • 批准号:
    8420439
  • 财政年份:
    2009
  • 资助金额:
    $ 44.49万
  • 项目类别:
Alcohol & Antiretrovirals in HIV Infection, Oxidative Stress and Liver Disease
酒精
  • 批准号:
    7590839
  • 财政年份:
    2008
  • 资助金额:
    $ 44.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了